Company / Revenue
BIOCRYST PHARMACEUTICALS INC Revenue History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$25.2M
FY2017
5-year range
-
FY2016-FY2017
Trend
-4.4%
vs FY2016
Sector context
#127 of 155
Health Care
What the data says
BIOCRYST PHARMACEUTICALS INC's revenue of $25M is lower than 82% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
$25M in FY2017.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 155This company $25.2M Sector average $4.5B
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2017, revenue decreased 4.4% year-over-year.
- Ranks #127 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $25.2M | -4.4% |
| FY2016 | $26.4M | -45.4% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026